nodes	percent_of_prediction	percent_of_DWPC	metapath
Niacin—SLCO2B1—Erlotinib—pancreatic cancer	0.227	0.728	CbGbCtD
Niacin—CYP2D6—Tamoxifen—pancreatic cancer	0.0373	0.12	CbGbCtD
Niacin—CYP2D6—Erlotinib—pancreatic cancer	0.0317	0.102	CbGbCtD
Niacin—HCAR3—pancreas—pancreatic cancer	0.0159	0.204	CbGeAlD
Niacin—CYP2D6—Doxorubicin—pancreatic cancer	0.0156	0.0502	CbGbCtD
Niacin—NNMT—gall bladder—pancreatic cancer	0.0129	0.165	CbGeAlD
Niacin—HCAR2—pancreas—pancreatic cancer	0.0105	0.135	CbGeAlD
Niacin—NNMT—islet of Langerhans—pancreatic cancer	0.00843	0.108	CbGeAlD
Niacin—SLC16A3—Azacitidine—Gemcitabine—pancreatic cancer	0.00636	1	CbGdCrCtD
Niacin—NNMT—pancreas—pancreatic cancer	0.00593	0.0761	CbGeAlD
Niacin—SLC16A3—islet of Langerhans—pancreatic cancer	0.00576	0.074	CbGeAlD
Niacin—NNMT—digestive system—pancreatic cancer	0.00506	0.065	CbGeAlD
Niacin—SLC16A3—pancreas—pancreatic cancer	0.00405	0.052	CbGeAlD
Niacin—SLC16A3—digestive system—pancreatic cancer	0.00346	0.0444	CbGeAlD
Niacin—SLC16A1—digestive system—pancreatic cancer	0.0021	0.027	CbGeAlD
Niacin—SLCO2B1—digestive system—pancreatic cancer	0.00181	0.0232	CbGeAlD
Niacin—SLC22A5—digestive system—pancreatic cancer	0.0012	0.0154	CbGeAlD
Niacin—CYP2D6—digestive system—pancreatic cancer	0.000774	0.00994	CbGeAlD
Niacin—Dry skin—Epirubicin—pancreatic cancer	0.000294	0.000831	CcSEcCtD
Niacin—Decreased appetite—Irinotecan—pancreatic cancer	0.000294	0.000831	CcSEcCtD
Niacin—Arrhythmia—Docetaxel—pancreatic cancer	0.000294	0.000831	CcSEcCtD
Niacin—Dyspnoea—Gemcitabine—pancreatic cancer	0.000294	0.00083	CcSEcCtD
Niacin—Orthostatic hypotension—Epirubicin—pancreatic cancer	0.000293	0.000828	CcSEcCtD
Niacin—Insomnia—Fluorouracil—pancreatic cancer	0.000293	0.000828	CcSEcCtD
Niacin—Somnolence—Gemcitabine—pancreatic cancer	0.000293	0.000828	CcSEcCtD
Niacin—Migraine—Doxorubicin—pancreatic cancer	0.000293	0.000826	CcSEcCtD
Niacin—Gastrointestinal disorder—Irinotecan—pancreatic cancer	0.000292	0.000825	CcSEcCtD
Niacin—Paraesthesia—Fluorouracil—pancreatic cancer	0.000291	0.000822	CcSEcCtD
Niacin—Alopecia—Docetaxel—pancreatic cancer	0.000291	0.000822	CcSEcCtD
Niacin—Pruritus—Sunitinib—pancreatic cancer	0.000291	0.000821	CcSEcCtD
Niacin—Pain—Irinotecan—pancreatic cancer	0.00029	0.000818	CcSEcCtD
Niacin—Dyspnoea—Fluorouracil—pancreatic cancer	0.000289	0.000816	CcSEcCtD
Niacin—Somnolence—Fluorouracil—pancreatic cancer	0.000288	0.000814	CcSEcCtD
Niacin—Face oedema—Doxorubicin—pancreatic cancer	0.000287	0.00081	CcSEcCtD
Niacin—Erythema—Docetaxel—pancreatic cancer	0.000287	0.00081	CcSEcCtD
Niacin—Malnutrition—Docetaxel—pancreatic cancer	0.000287	0.00081	CcSEcCtD
Niacin—Decreased appetite—Gemcitabine—pancreatic cancer	0.000287	0.00081	CcSEcCtD
Niacin—Dyspepsia—Fluorouracil—pancreatic cancer	0.000285	0.000806	CcSEcCtD
Niacin—Nausea—Tamoxifen—pancreatic cancer	0.000285	0.000805	CcSEcCtD
Niacin—Gastrointestinal disorder—Gemcitabine—pancreatic cancer	0.000285	0.000804	CcSEcCtD
Niacin—Muscular weakness—Epirubicin—pancreatic cancer	0.000283	0.0008	CcSEcCtD
Niacin—Pain—Gemcitabine—pancreatic cancer	0.000282	0.000796	CcSEcCtD
Niacin—Nausea—Erlotinib—pancreatic cancer	0.000282	0.000796	CcSEcCtD
Niacin—Decreased appetite—Fluorouracil—pancreatic cancer	0.000282	0.000796	CcSEcCtD
Niacin—Diarrhoea—Sunitinib—pancreatic cancer	0.000281	0.000794	CcSEcCtD
Niacin—Gastrointestinal disorder—Fluorouracil—pancreatic cancer	0.00028	0.00079	CcSEcCtD
Niacin—Abdominal distension—Epirubicin—pancreatic cancer	0.00028	0.000789	CcSEcCtD
Niacin—Influenza—Epirubicin—pancreatic cancer	0.000278	0.000784	CcSEcCtD
Niacin—Dysphagia—Epirubicin—pancreatic cancer	0.000278	0.000784	CcSEcCtD
Niacin—Pain—Fluorouracil—pancreatic cancer	0.000277	0.000783	CcSEcCtD
Niacin—Gastrointestinal pain—Irinotecan—pancreatic cancer	0.000277	0.000782	CcSEcCtD
Niacin—Muscle spasms—Docetaxel—pancreatic cancer	0.000276	0.000779	CcSEcCtD
Niacin—Liver function test abnormal—Doxorubicin—pancreatic cancer	0.000274	0.000775	CcSEcCtD
Niacin—Dry skin—Doxorubicin—pancreatic cancer	0.000272	0.000769	CcSEcCtD
Niacin—Dizziness—Sunitinib—pancreatic cancer	0.000272	0.000767	CcSEcCtD
Niacin—Orthostatic hypotension—Doxorubicin—pancreatic cancer	0.000271	0.000766	CcSEcCtD
Niacin—Angina pectoris—Epirubicin—pancreatic cancer	0.00027	0.000764	CcSEcCtD
Niacin—Abdominal pain—Irinotecan—pancreatic cancer	0.000268	0.000756	CcSEcCtD
Niacin—Body temperature increased—Irinotecan—pancreatic cancer	0.000268	0.000756	CcSEcCtD
Niacin—Bronchitis—Epirubicin—pancreatic cancer	0.000267	0.000754	CcSEcCtD
Niacin—Muscular weakness—Doxorubicin—pancreatic cancer	0.000262	0.00074	CcSEcCtD
Niacin—Vomiting—Sunitinib—pancreatic cancer	0.000261	0.000738	CcSEcCtD
Niacin—Body temperature increased—Gemcitabine—pancreatic cancer	0.000261	0.000736	CcSEcCtD
Niacin—Rash—Sunitinib—pancreatic cancer	0.000259	0.000732	CcSEcCtD
Niacin—Dermatitis—Sunitinib—pancreatic cancer	0.000259	0.000731	CcSEcCtD
Niacin—Abdominal distension—Doxorubicin—pancreatic cancer	0.000259	0.00073	CcSEcCtD
Niacin—Urticaria—Fluorouracil—pancreatic cancer	0.000258	0.000727	CcSEcCtD
Niacin—Headache—Sunitinib—pancreatic cancer	0.000258	0.000727	CcSEcCtD
Niacin—Syncope—Docetaxel—pancreatic cancer	0.000257	0.000726	CcSEcCtD
Niacin—Influenza—Doxorubicin—pancreatic cancer	0.000257	0.000725	CcSEcCtD
Niacin—Dysphagia—Doxorubicin—pancreatic cancer	0.000257	0.000725	CcSEcCtD
Niacin—Leukopenia—Docetaxel—pancreatic cancer	0.000257	0.000725	CcSEcCtD
Niacin—Body temperature increased—Fluorouracil—pancreatic cancer	0.000256	0.000724	CcSEcCtD
Niacin—Palpitations—Docetaxel—pancreatic cancer	0.000253	0.000716	CcSEcCtD
Niacin—Loss of consciousness—Docetaxel—pancreatic cancer	0.000252	0.000712	CcSEcCtD
Niacin—Cough—Docetaxel—pancreatic cancer	0.00025	0.000707	CcSEcCtD
Niacin—Angina pectoris—Doxorubicin—pancreatic cancer	0.00025	0.000706	CcSEcCtD
Niacin—Hypersensitivity—Irinotecan—pancreatic cancer	0.000249	0.000704	CcSEcCtD
Niacin—Bronchitis—Doxorubicin—pancreatic cancer	0.000247	0.000698	CcSEcCtD
Niacin—Arthralgia—Docetaxel—pancreatic cancer	0.000244	0.000689	CcSEcCtD
Niacin—Myalgia—Docetaxel—pancreatic cancer	0.000244	0.000689	CcSEcCtD
Niacin—Nausea—Sunitinib—pancreatic cancer	0.000244	0.000689	CcSEcCtD
Niacin—Asthenia—Irinotecan—pancreatic cancer	0.000243	0.000686	CcSEcCtD
Niacin—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—pancreatic cancer	0.000242	0.000685	CcSEcCtD
Niacin—Stomatitis—Epirubicin—pancreatic cancer	0.000241	0.000681	CcSEcCtD
Niacin—Jaundice—Epirubicin—pancreatic cancer	0.000241	0.000681	CcSEcCtD
Niacin—Hypersensitivity—Fluorouracil—pancreatic cancer	0.000239	0.000675	CcSEcCtD
Niacin—Dry mouth—Docetaxel—pancreatic cancer	0.000239	0.000674	CcSEcCtD
Niacin—Sweating—Epirubicin—pancreatic cancer	0.000237	0.00067	CcSEcCtD
Niacin—Asthenia—Gemcitabine—pancreatic cancer	0.000237	0.000668	CcSEcCtD
Niacin—Oedema—Docetaxel—pancreatic cancer	0.000234	0.000661	CcSEcCtD
Niacin—Anaphylactic shock—Docetaxel—pancreatic cancer	0.000234	0.000661	CcSEcCtD
Niacin—Pruritus—Gemcitabine—pancreatic cancer	0.000233	0.000659	CcSEcCtD
Niacin—Diarrhoea—Irinotecan—pancreatic cancer	0.000232	0.000654	CcSEcCtD
Niacin—Shock—Docetaxel—pancreatic cancer	0.00023	0.00065	CcSEcCtD
Niacin—Pruritus—Fluorouracil—pancreatic cancer	0.000229	0.000648	CcSEcCtD
Niacin—Tachycardia—Docetaxel—pancreatic cancer	0.000228	0.000645	CcSEcCtD
Niacin—Skin disorder—Docetaxel—pancreatic cancer	0.000227	0.000642	CcSEcCtD
Niacin—Diarrhoea—Gemcitabine—pancreatic cancer	0.000226	0.000637	CcSEcCtD
Niacin—Dizziness—Irinotecan—pancreatic cancer	0.000224	0.000632	CcSEcCtD
Niacin—Haemoglobin—Epirubicin—pancreatic cancer	0.000223	0.000631	CcSEcCtD
Niacin—Stomatitis—Doxorubicin—pancreatic cancer	0.000223	0.00063	CcSEcCtD
Niacin—Jaundice—Doxorubicin—pancreatic cancer	0.000223	0.00063	CcSEcCtD
Niacin—Anorexia—Docetaxel—pancreatic cancer	0.000223	0.00063	CcSEcCtD
Niacin—Rhinitis—Epirubicin—pancreatic cancer	0.000223	0.000629	CcSEcCtD
Niacin—Hepatitis—Epirubicin—pancreatic cancer	0.000222	0.000627	CcSEcCtD
Niacin—Haemorrhage—Epirubicin—pancreatic cancer	0.000222	0.000627	CcSEcCtD
Niacin—Diarrhoea—Fluorouracil—pancreatic cancer	0.000222	0.000626	CcSEcCtD
Niacin—Hypoaesthesia—Epirubicin—pancreatic cancer	0.000221	0.000624	CcSEcCtD
Niacin—Sweating—Doxorubicin—pancreatic cancer	0.00022	0.00062	CcSEcCtD
Niacin—Oedema peripheral—Epirubicin—pancreatic cancer	0.000219	0.000618	CcSEcCtD
Niacin—Hypotension—Docetaxel—pancreatic cancer	0.000219	0.000618	CcSEcCtD
Niacin—Vomiting—Irinotecan—pancreatic cancer	0.000215	0.000608	CcSEcCtD
Niacin—Dizziness—Fluorouracil—pancreatic cancer	0.000214	0.000605	CcSEcCtD
Niacin—Visual impairment—Epirubicin—pancreatic cancer	0.000214	0.000605	CcSEcCtD
Niacin—HCAR2—Signaling Pathways—PTHLH—pancreatic cancer	0.000214	0.000855	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—PTCH1—pancreatic cancer	0.000214	0.000855	CbGpPWpGaD
Niacin—Rash—Irinotecan—pancreatic cancer	0.000214	0.000603	CcSEcCtD
Niacin—Dermatitis—Irinotecan—pancreatic cancer	0.000213	0.000602	CcSEcCtD
Niacin—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	0.000213	0.000602	CcSEcCtD
Niacin—HCAR3—Signaling Pathways—NOTCH4—pancreatic cancer	0.000212	0.00085	CbGpPWpGaD
Niacin—Headache—Irinotecan—pancreatic cancer	0.000212	0.000599	CcSEcCtD
Niacin—Insomnia—Docetaxel—pancreatic cancer	0.000212	0.000598	CcSEcCtD
Niacin—HCAR3—Signaling Pathways—IAPP—pancreatic cancer	0.000211	0.000844	CbGpPWpGaD
Niacin—Paraesthesia—Docetaxel—pancreatic cancer	0.00021	0.000593	CcSEcCtD
Niacin—Vomiting—Gemcitabine—pancreatic cancer	0.00021	0.000592	CcSEcCtD
Niacin—Dyspnoea—Docetaxel—pancreatic cancer	0.000209	0.000589	CcSEcCtD
Niacin—NNMT—Metabolism—STK11—pancreatic cancer	0.000208	0.000834	CbGpPWpGaD
Niacin—Somnolence—Docetaxel—pancreatic cancer	0.000208	0.000588	CcSEcCtD
Niacin—Rash—Gemcitabine—pancreatic cancer	0.000208	0.000587	CcSEcCtD
Niacin—Dermatitis—Gemcitabine—pancreatic cancer	0.000208	0.000587	CcSEcCtD
Niacin—Eye disorder—Epirubicin—pancreatic cancer	0.000208	0.000586	CcSEcCtD
Niacin—Tinnitus—Epirubicin—pancreatic cancer	0.000207	0.000585	CcSEcCtD
Niacin—Haemoglobin—Doxorubicin—pancreatic cancer	0.000207	0.000583	CcSEcCtD
Niacin—Headache—Gemcitabine—pancreatic cancer	0.000207	0.000583	CcSEcCtD
Niacin—Flushing—Epirubicin—pancreatic cancer	0.000206	0.000582	CcSEcCtD
Niacin—Vomiting—Fluorouracil—pancreatic cancer	0.000206	0.000582	CcSEcCtD
Niacin—Rhinitis—Doxorubicin—pancreatic cancer	0.000206	0.000582	CcSEcCtD
Niacin—Dyspepsia—Docetaxel—pancreatic cancer	0.000206	0.000582	CcSEcCtD
Niacin—Hepatitis—Doxorubicin—pancreatic cancer	0.000206	0.000581	CcSEcCtD
Niacin—Haemorrhage—Doxorubicin—pancreatic cancer	0.000206	0.000581	CcSEcCtD
Niacin—Hypoaesthesia—Doxorubicin—pancreatic cancer	0.000205	0.000578	CcSEcCtD
Niacin—Rash—Fluorouracil—pancreatic cancer	0.000204	0.000577	CcSEcCtD
Niacin—Dermatitis—Fluorouracil—pancreatic cancer	0.000204	0.000577	CcSEcCtD
Niacin—Decreased appetite—Docetaxel—pancreatic cancer	0.000203	0.000574	CcSEcCtD
Niacin—Headache—Fluorouracil—pancreatic cancer	0.000203	0.000574	CcSEcCtD
Niacin—Oedema peripheral—Doxorubicin—pancreatic cancer	0.000203	0.000572	CcSEcCtD
Niacin—HCAR3—Signaling Pathways—PTCH1—pancreatic cancer	0.000203	0.00081	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—PTHLH—pancreatic cancer	0.000203	0.00081	CbGpPWpGaD
Niacin—Gastrointestinal disorder—Docetaxel—pancreatic cancer	0.000202	0.000571	CcSEcCtD
Niacin—Angiopathy—Epirubicin—pancreatic cancer	0.000202	0.000569	CcSEcCtD
Niacin—Nausea—Irinotecan—pancreatic cancer	0.000201	0.000568	CcSEcCtD
Niacin—QPRT—Disease—TERT—pancreatic cancer	0.0002	0.000802	CbGpPWpGaD
Niacin—Pain—Docetaxel—pancreatic cancer	0.0002	0.000565	CcSEcCtD
Niacin—Chills—Epirubicin—pancreatic cancer	0.000199	0.000563	CcSEcCtD
Niacin—Arrhythmia—Epirubicin—pancreatic cancer	0.000199	0.00056	CcSEcCtD
Niacin—Visual impairment—Doxorubicin—pancreatic cancer	0.000198	0.000559	CcSEcCtD
Niacin—Alopecia—Epirubicin—pancreatic cancer	0.000196	0.000554	CcSEcCtD
Niacin—Nausea—Gemcitabine—pancreatic cancer	0.000196	0.000553	CcSEcCtD
Niacin—HCAR2—Signaling Pathways—SST—pancreatic cancer	0.000195	0.000782	CbGpPWpGaD
Niacin—SLC16A1—Cell surface interactions at the vascular wall—SRC—pancreatic cancer	0.000194	0.000775	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—TYMP—pancreatic cancer	0.000194	0.000775	CbGpPWpGaD
Niacin—Erythema—Epirubicin—pancreatic cancer	0.000193	0.000546	CcSEcCtD
Niacin—Malnutrition—Epirubicin—pancreatic cancer	0.000193	0.000546	CcSEcCtD
Niacin—HCAR2—GPCR downstream signaling—PIK3CG—pancreatic cancer	0.000193	0.000771	CbGpPWpGaD
Niacin—QPRT—Metabolism—TYMS—pancreatic cancer	0.000193	0.000771	CbGpPWpGaD
Niacin—Nausea—Fluorouracil—pancreatic cancer	0.000193	0.000544	CcSEcCtD
Niacin—Eye disorder—Doxorubicin—pancreatic cancer	0.000192	0.000543	CcSEcCtD
Niacin—Tinnitus—Doxorubicin—pancreatic cancer	0.000192	0.000541	CcSEcCtD
Niacin—QPRT—Disease—HIF1A—pancreatic cancer	0.000192	0.000767	CbGpPWpGaD
Niacin—Gastrointestinal pain—Docetaxel—pancreatic cancer	0.000191	0.00054	CcSEcCtD
Niacin—QPRT—Disease—TSC2—pancreatic cancer	0.000191	0.000765	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—JAG1—pancreatic cancer	0.000191	0.000765	CbGpPWpGaD
Niacin—Flushing—Doxorubicin—pancreatic cancer	0.000191	0.000539	CcSEcCtD
Niacin—Flatulence—Epirubicin—pancreatic cancer	0.000191	0.000538	CcSEcCtD
Niacin—HCAR2—Signaling Pathways—NOTCH3—pancreatic cancer	0.00019	0.000762	CbGpPWpGaD
Niacin—Tension—Epirubicin—pancreatic cancer	0.00019	0.000536	CcSEcCtD
Niacin—SLCO2B1—Transmembrane transport of small molecules—SLC2A2—pancreatic cancer	0.000189	0.000757	CbGpPWpGaD
Niacin—Nervousness—Epirubicin—pancreatic cancer	0.000188	0.00053	CcSEcCtD
Niacin—QPRT—Disease—APOE—pancreatic cancer	0.000187	0.000749	CbGpPWpGaD
Niacin—Angiopathy—Doxorubicin—pancreatic cancer	0.000187	0.000527	CcSEcCtD
Niacin—SLC16A1—Cell surface interactions at the vascular wall—NRAS—pancreatic cancer	0.000186	0.000746	CbGpPWpGaD
Niacin—Muscle spasms—Epirubicin—pancreatic cancer	0.000186	0.000525	CcSEcCtD
Niacin—HCAR3—Signaling Pathways—SST—pancreatic cancer	0.000185	0.000741	CbGpPWpGaD
Niacin—Body temperature increased—Docetaxel—pancreatic cancer	0.000185	0.000522	CcSEcCtD
Niacin—Abdominal pain—Docetaxel—pancreatic cancer	0.000185	0.000522	CcSEcCtD
Niacin—Chills—Doxorubicin—pancreatic cancer	0.000184	0.000521	CcSEcCtD
Niacin—Arrhythmia—Doxorubicin—pancreatic cancer	0.000184	0.000519	CcSEcCtD
Niacin—HCAR3—GPCR downstream signaling—PIK3CG—pancreatic cancer	0.000183	0.000731	CbGpPWpGaD
Niacin—Vision blurred—Epirubicin—pancreatic cancer	0.000182	0.000515	CcSEcCtD
Niacin—Alopecia—Doxorubicin—pancreatic cancer	0.000182	0.000513	CcSEcCtD
Niacin—HCAR3—Signaling Pathways—JAG1—pancreatic cancer	0.000181	0.000725	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—NOTCH3—pancreatic cancer	0.000181	0.000722	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—CNR1—pancreatic cancer	0.00018	0.000722	CbGpPWpGaD
Niacin—NNMT—Metabolism—TYMS—pancreatic cancer	0.000179	0.000717	CbGpPWpGaD
Niacin—Malnutrition—Doxorubicin—pancreatic cancer	0.000179	0.000505	CcSEcCtD
Niacin—Erythema—Doxorubicin—pancreatic cancer	0.000179	0.000505	CcSEcCtD
Niacin—SLC16A3—Hemostasis—PLAU—pancreatic cancer	0.000178	0.000712	CbGpPWpGaD
Niacin—Flatulence—Doxorubicin—pancreatic cancer	0.000176	0.000498	CcSEcCtD
Niacin—Tension—Doxorubicin—pancreatic cancer	0.000176	0.000496	CcSEcCtD
Niacin—HCAR2—Signaling by GPCR—PIK3CG—pancreatic cancer	0.000175	0.0007	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—GCG—pancreatic cancer	0.000174	0.000697	CbGpPWpGaD
Niacin—Nervousness—Doxorubicin—pancreatic cancer	0.000174	0.000491	CcSEcCtD
Niacin—Vertigo—Epirubicin—pancreatic cancer	0.000174	0.000491	CcSEcCtD
Niacin—Syncope—Epirubicin—pancreatic cancer	0.000173	0.00049	CcSEcCtD
Niacin—Leukopenia—Epirubicin—pancreatic cancer	0.000173	0.000489	CcSEcCtD
Niacin—QPRT—Disease—NOTCH1—pancreatic cancer	0.000173	0.000691	CbGpPWpGaD
Niacin—Hypersensitivity—Docetaxel—pancreatic cancer	0.000172	0.000487	CcSEcCtD
Niacin—Muscle spasms—Doxorubicin—pancreatic cancer	0.000172	0.000486	CcSEcCtD
Niacin—Palpitations—Epirubicin—pancreatic cancer	0.000171	0.000483	CcSEcCtD
Niacin—HCAR3—Signaling Pathways—CNR1—pancreatic cancer	0.000171	0.000684	CbGpPWpGaD
Niacin—Loss of consciousness—Epirubicin—pancreatic cancer	0.00017	0.00048	CcSEcCtD
Niacin—HCAR2—GPCR downstream signaling—PIK3CD—pancreatic cancer	0.000169	0.000678	CbGpPWpGaD
Niacin—Cough—Epirubicin—pancreatic cancer	0.000169	0.000477	CcSEcCtD
Niacin—Vision blurred—Doxorubicin—pancreatic cancer	0.000169	0.000476	CcSEcCtD
Niacin—SLC16A1—Transmembrane transport of small molecules—SLC2A2—pancreatic cancer	0.000168	0.000672	CbGpPWpGaD
Niacin—Asthenia—Docetaxel—pancreatic cancer	0.000168	0.000474	CcSEcCtD
Niacin—QPRT—Disease—EGF—pancreatic cancer	0.000167	0.000668	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—AGTR1—pancreatic cancer	0.000166	0.000665	CbGpPWpGaD
Niacin—HCAR3—Signaling by GPCR—PIK3CG—pancreatic cancer	0.000166	0.000664	CbGpPWpGaD
Niacin—Pruritus—Docetaxel—pancreatic cancer	0.000166	0.000468	CcSEcCtD
Niacin—HCAR3—Signaling Pathways—GCG—pancreatic cancer	0.000165	0.000661	CbGpPWpGaD
Niacin—Arthralgia—Epirubicin—pancreatic cancer	0.000165	0.000465	CcSEcCtD
Niacin—Myalgia—Epirubicin—pancreatic cancer	0.000165	0.000465	CcSEcCtD
Niacin—HCAR2—Signaling Pathways—STK11—pancreatic cancer	0.000164	0.000655	CbGpPWpGaD
Niacin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—pancreatic cancer	0.000164	0.000462	CcSEcCtD
Niacin—Dry mouth—Epirubicin—pancreatic cancer	0.000161	0.000455	CcSEcCtD
Niacin—Vertigo—Doxorubicin—pancreatic cancer	0.000161	0.000454	CcSEcCtD
Niacin—HCAR3—GPCR downstream signaling—PIK3CD—pancreatic cancer	0.000161	0.000643	CbGpPWpGaD
Niacin—Syncope—Doxorubicin—pancreatic cancer	0.000161	0.000453	CcSEcCtD
Niacin—SLC16A1—Cell surface interactions at the vascular wall—KRAS—pancreatic cancer	0.00016	0.000642	CbGpPWpGaD
Niacin—Leukopenia—Doxorubicin—pancreatic cancer	0.00016	0.000452	CcSEcCtD
Niacin—Diarrhoea—Docetaxel—pancreatic cancer	0.00016	0.000452	CcSEcCtD
Niacin—SLC16A3—Hemostasis—PIK3CG—pancreatic cancer	0.000158	0.000634	CbGpPWpGaD
Niacin—Palpitations—Doxorubicin—pancreatic cancer	0.000158	0.000447	CcSEcCtD
Niacin—Oedema—Epirubicin—pancreatic cancer	0.000158	0.000446	CcSEcCtD
Niacin—Anaphylactic shock—Epirubicin—pancreatic cancer	0.000158	0.000446	CcSEcCtD
Niacin—HCAR3—Signaling Pathways—AGTR1—pancreatic cancer	0.000157	0.00063	CbGpPWpGaD
Niacin—Loss of consciousness—Doxorubicin—pancreatic cancer	0.000157	0.000444	CcSEcCtD
Niacin—QPRT—Metabolism—APOE—pancreatic cancer	0.000157	0.000627	CbGpPWpGaD
Niacin—SLC16A3—Hemostasis—EGF—pancreatic cancer	0.000157	0.000627	CbGpPWpGaD
Niacin—Cough—Doxorubicin—pancreatic cancer	0.000156	0.000441	CcSEcCtD
Niacin—SLC16A3—Metabolism—GLP1R—pancreatic cancer	0.000156	0.000625	CbGpPWpGaD
Niacin—Shock—Epirubicin—pancreatic cancer	0.000155	0.000439	CcSEcCtD
Niacin—HCAR3—Signaling Pathways—STK11—pancreatic cancer	0.000155	0.000621	CbGpPWpGaD
Niacin—Dizziness—Docetaxel—pancreatic cancer	0.000155	0.000437	CcSEcCtD
Niacin—Tachycardia—Epirubicin—pancreatic cancer	0.000154	0.000435	CcSEcCtD
Niacin—HCAR2—Signaling by GPCR—PIK3CD—pancreatic cancer	0.000154	0.000616	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—DPYD—pancreatic cancer	0.000154	0.000614	CbGpPWpGaD
Niacin—Skin disorder—Epirubicin—pancreatic cancer	0.000153	0.000433	CcSEcCtD
Niacin—Hyperhidrosis—Epirubicin—pancreatic cancer	0.000153	0.000431	CcSEcCtD
Niacin—Myalgia—Doxorubicin—pancreatic cancer	0.000152	0.00043	CcSEcCtD
Niacin—Arthralgia—Doxorubicin—pancreatic cancer	0.000152	0.00043	CcSEcCtD
Niacin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—pancreatic cancer	0.000151	0.000427	CcSEcCtD
Niacin—Anorexia—Epirubicin—pancreatic cancer	0.00015	0.000425	CcSEcCtD
Niacin—SLC16A1—Hemostasis—CD44—pancreatic cancer	0.00015	0.000601	CbGpPWpGaD
Niacin—Dry mouth—Doxorubicin—pancreatic cancer	0.000149	0.000421	CcSEcCtD
Niacin—Vomiting—Docetaxel—pancreatic cancer	0.000149	0.00042	CcSEcCtD
Niacin—QPRT—Disease—PIK3CD—pancreatic cancer	0.000148	0.000594	CbGpPWpGaD
Niacin—HCAR2—GPCR downstream signaling—PIK3CB—pancreatic cancer	0.000148	0.000591	CbGpPWpGaD
Niacin—Rash—Docetaxel—pancreatic cancer	0.000148	0.000417	CcSEcCtD
Niacin—Hypotension—Epirubicin—pancreatic cancer	0.000148	0.000417	CcSEcCtD
Niacin—Dermatitis—Docetaxel—pancreatic cancer	0.000147	0.000416	CcSEcCtD
Niacin—SLC16A1—Cell surface interactions at the vascular wall—PIK3CA—pancreatic cancer	0.000147	0.00059	CbGpPWpGaD
Niacin—Headache—Docetaxel—pancreatic cancer	0.000147	0.000414	CcSEcCtD
Niacin—Anaphylactic shock—Doxorubicin—pancreatic cancer	0.000146	0.000412	CcSEcCtD
Niacin—Oedema—Doxorubicin—pancreatic cancer	0.000146	0.000412	CcSEcCtD
Niacin—HCAR3—Signaling by GPCR—PIK3CD—pancreatic cancer	0.000146	0.000584	CbGpPWpGaD
Niacin—NNMT—Metabolism—APOE—pancreatic cancer	0.000146	0.000583	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—SLC2A2—pancreatic cancer	0.000146	0.000583	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—IFNA1—pancreatic cancer	0.000146	0.000582	CbGpPWpGaD
Niacin—SLC22A5—Transmembrane transport of small molecules—SLC2A2—pancreatic cancer	0.000144	0.000578	CbGpPWpGaD
Niacin—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	0.000144	0.000406	CcSEcCtD
Niacin—Shock—Doxorubicin—pancreatic cancer	0.000144	0.000406	CcSEcCtD
Niacin—HCAR2—Signaling Pathways—SMAD4—pancreatic cancer	0.000143	0.000574	CbGpPWpGaD
Niacin—Insomnia—Epirubicin—pancreatic cancer	0.000143	0.000403	CcSEcCtD
Niacin—Tachycardia—Doxorubicin—pancreatic cancer	0.000143	0.000403	CcSEcCtD
Niacin—HCAR2—GPCR downstream signaling—CXCL8—pancreatic cancer	0.000142	0.000568	CbGpPWpGaD
Niacin—Skin disorder—Doxorubicin—pancreatic cancer	0.000142	0.000401	CcSEcCtD
Niacin—Paraesthesia—Epirubicin—pancreatic cancer	0.000142	0.0004	CcSEcCtD
Niacin—QPRT—Metabolism—PIK3CG—pancreatic cancer	0.000141	0.000566	CbGpPWpGaD
Niacin—Hyperhidrosis—Doxorubicin—pancreatic cancer	0.000141	0.000399	CcSEcCtD
Niacin—Dyspnoea—Epirubicin—pancreatic cancer	0.000141	0.000397	CcSEcCtD
Niacin—Somnolence—Epirubicin—pancreatic cancer	0.00014	0.000396	CcSEcCtD
Niacin—HCAR2—Signaling Pathways—HES1—pancreatic cancer	0.00014	0.00056	CbGpPWpGaD
Niacin—HCAR3—GPCR downstream signaling—PIK3CB—pancreatic cancer	0.00014	0.00056	CbGpPWpGaD
Niacin—Anorexia—Doxorubicin—pancreatic cancer	0.000139	0.000393	CcSEcCtD
Niacin—SLC16A3—Hemostasis—PIK3CD—pancreatic cancer	0.000139	0.000557	CbGpPWpGaD
Niacin—Nausea—Docetaxel—pancreatic cancer	0.000139	0.000393	CcSEcCtD
Niacin—Dyspepsia—Epirubicin—pancreatic cancer	0.000139	0.000392	CcSEcCtD
Niacin—SLC16A1—Metabolism—PRSS1—pancreatic cancer	0.000138	0.000552	CbGpPWpGaD
Niacin—Decreased appetite—Epirubicin—pancreatic cancer	0.000137	0.000387	CcSEcCtD
Niacin—QPRT—Metabolism—PPARG—pancreatic cancer	0.000137	0.000546	CbGpPWpGaD
Niacin—Hypotension—Doxorubicin—pancreatic cancer	0.000137	0.000385	CcSEcCtD
Niacin—SLC16A1—Cell surface interactions at the vascular wall—HRAS—pancreatic cancer	0.000136	0.000546	CbGpPWpGaD
Niacin—Gastrointestinal disorder—Epirubicin—pancreatic cancer	0.000136	0.000385	CcSEcCtD
Niacin—HCAR3—Signaling Pathways—SMAD4—pancreatic cancer	0.000136	0.000544	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—IFNA2—pancreatic cancer	0.000135	0.000542	CbGpPWpGaD
Niacin—Pain—Epirubicin—pancreatic cancer	0.000135	0.000381	CcSEcCtD
Niacin—HCAR3—GPCR downstream signaling—CXCL8—pancreatic cancer	0.000135	0.000538	CbGpPWpGaD
Niacin—HCAR2—Signaling by GPCR—PIK3CB—pancreatic cancer	0.000134	0.000537	CbGpPWpGaD
Niacin—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	0.000133	0.000376	CcSEcCtD
Niacin—HCAR3—Signaling Pathways—HES1—pancreatic cancer	0.000133	0.000531	CbGpPWpGaD
Niacin—Insomnia—Doxorubicin—pancreatic cancer	0.000132	0.000373	CcSEcCtD
Niacin—NNMT—Metabolism—PIK3CG—pancreatic cancer	0.000131	0.000526	CbGpPWpGaD
Niacin—Paraesthesia—Doxorubicin—pancreatic cancer	0.000131	0.00037	CcSEcCtD
Niacin—Dyspnoea—Doxorubicin—pancreatic cancer	0.00013	0.000368	CcSEcCtD
Niacin—Somnolence—Doxorubicin—pancreatic cancer	0.00013	0.000367	CcSEcCtD
Niacin—QPRT—Disease—PIK3CB—pancreatic cancer	0.000129	0.000518	CbGpPWpGaD
Niacin—Gastrointestinal pain—Epirubicin—pancreatic cancer	0.000129	0.000364	CcSEcCtD
Niacin—HCAR2—Signaling by GPCR—CXCL8—pancreatic cancer	0.000129	0.000516	CbGpPWpGaD
Niacin—Dyspepsia—Doxorubicin—pancreatic cancer	0.000129	0.000363	CcSEcCtD
Niacin—QPRT—Disease—PTGS2—pancreatic cancer	0.000128	0.000513	CbGpPWpGaD
Niacin—HCAR3—Signaling by GPCR—PIK3CB—pancreatic cancer	0.000127	0.000509	CbGpPWpGaD
Niacin—Decreased appetite—Doxorubicin—pancreatic cancer	0.000127	0.000359	CcSEcCtD
Niacin—NNMT—Metabolism—PPARG—pancreatic cancer	0.000127	0.000508	CbGpPWpGaD
Niacin—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	0.000126	0.000356	CcSEcCtD
Niacin—Urticaria—Epirubicin—pancreatic cancer	0.000125	0.000354	CcSEcCtD
Niacin—Pain—Doxorubicin—pancreatic cancer	0.000125	0.000353	CcSEcCtD
Niacin—Body temperature increased—Epirubicin—pancreatic cancer	0.000125	0.000352	CcSEcCtD
Niacin—Abdominal pain—Epirubicin—pancreatic cancer	0.000125	0.000352	CcSEcCtD
Niacin—QPRT—Metabolism—PIK3CD—pancreatic cancer	0.000124	0.000498	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—TERT—pancreatic cancer	0.000123	0.000491	CbGpPWpGaD
Niacin—HCAR3—Signaling by GPCR—CXCL8—pancreatic cancer	0.000122	0.000489	CbGpPWpGaD
Niacin—SLC16A3—Hemostasis—PIK3CB—pancreatic cancer	0.000121	0.000486	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—ARG2—pancreatic cancer	0.00012	0.000479	CbGpPWpGaD
Niacin—Gastrointestinal pain—Doxorubicin—pancreatic cancer	0.000119	0.000337	CcSEcCtD
Niacin—HCAR2—Signaling Pathways—HIF1A—pancreatic cancer	0.000117	0.00047	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—TSC2—pancreatic cancer	0.000117	0.000468	CbGpPWpGaD
Niacin—Hypersensitivity—Epirubicin—pancreatic cancer	0.000116	0.000328	CcSEcCtD
Niacin—HCAR3—Signaling Pathways—TERT—pancreatic cancer	0.000116	0.000466	CbGpPWpGaD
Niacin—Urticaria—Doxorubicin—pancreatic cancer	0.000116	0.000328	CcSEcCtD
Niacin—NNMT—Metabolism—PIK3CD—pancreatic cancer	0.000116	0.000463	CbGpPWpGaD
Niacin—Body temperature increased—Doxorubicin—pancreatic cancer	0.000115	0.000326	CcSEcCtD
Niacin—Abdominal pain—Doxorubicin—pancreatic cancer	0.000115	0.000326	CcSEcCtD
Niacin—QPRT—Disease—CTNNB1—pancreatic cancer	0.000115	0.000459	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—APOE—pancreatic cancer	0.000115	0.000458	CbGpPWpGaD
Niacin—Asthenia—Epirubicin—pancreatic cancer	0.000113	0.00032	CcSEcCtD
Niacin—SLC16A3—Metabolism—CD44—pancreatic cancer	0.000113	0.000452	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—KDR—pancreatic cancer	0.000112	0.000449	CbGpPWpGaD
Niacin—QPRT—Disease—PTEN—pancreatic cancer	0.000112	0.000448	CbGpPWpGaD
Niacin—Pruritus—Epirubicin—pancreatic cancer	0.000112	0.000315	CcSEcCtD
Niacin—HCAR3—Signaling Pathways—HIF1A—pancreatic cancer	0.000111	0.000445	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—TSC2—pancreatic cancer	0.000111	0.000444	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—APOE—pancreatic cancer	0.000109	0.000435	CbGpPWpGaD
Niacin—QPRT—Metabolism—PIK3CB—pancreatic cancer	0.000108	0.000434	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—GCG—pancreatic cancer	0.000108	0.000433	CbGpPWpGaD
Niacin—Diarrhoea—Epirubicin—pancreatic cancer	0.000108	0.000305	CcSEcCtD
Niacin—Hypersensitivity—Doxorubicin—pancreatic cancer	0.000108	0.000304	CcSEcCtD
Niacin—QPRT—Metabolism—PTGS2—pancreatic cancer	0.000107	0.00043	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—NFKBIA—pancreatic cancer	0.000107	0.000427	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—KDR—pancreatic cancer	0.000106	0.000426	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—NOTCH1—pancreatic cancer	0.000106	0.000423	CbGpPWpGaD
Niacin—Asthenia—Doxorubicin—pancreatic cancer	0.000105	0.000296	CcSEcCtD
Niacin—SLC16A1—Metabolism—TYMP—pancreatic cancer	0.000105	0.000418	CbGpPWpGaD
Niacin—Dizziness—Epirubicin—pancreatic cancer	0.000104	0.000295	CcSEcCtD
Niacin—QPRT—Disease—SRC—pancreatic cancer	0.000104	0.000415	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—PIK3CG—pancreatic cancer	0.000103	0.000414	CbGpPWpGaD
Niacin—HCAR2—Signaling by GPCR—NRAS—pancreatic cancer	0.000103	0.000414	CbGpPWpGaD
Niacin—Pruritus—Doxorubicin—pancreatic cancer	0.000103	0.000292	CcSEcCtD
Niacin—HCAR2—Signaling Pathways—EGF—pancreatic cancer	0.000102	0.000409	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—STK11—pancreatic cancer	0.000102	0.000407	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—NFKBIA—pancreatic cancer	0.000101	0.000405	CbGpPWpGaD
Niacin—NNMT—Metabolism—PIK3CB—pancreatic cancer	0.000101	0.000403	CbGpPWpGaD
Niacin—Vomiting—Epirubicin—pancreatic cancer	0.0001	0.000283	CcSEcCtD
Niacin—HCAR3—Signaling Pathways—NOTCH1—pancreatic cancer	0.0001	0.000401	CbGpPWpGaD
Niacin—QPRT—Disease—STAT3—pancreatic cancer	0.0001	0.0004	CbGpPWpGaD
Niacin—Diarrhoea—Doxorubicin—pancreatic cancer	0.0001	0.000282	CcSEcCtD
Niacin—NNMT—Metabolism—PTGS2—pancreatic cancer	9.98e-05	0.0004	CbGpPWpGaD
Niacin—QPRT—Disease—NRAS—pancreatic cancer	9.98e-05	0.000399	CbGpPWpGaD
Niacin—Rash—Epirubicin—pancreatic cancer	9.95e-05	0.000281	CcSEcCtD
Niacin—Dermatitis—Epirubicin—pancreatic cancer	9.95e-05	0.000281	CcSEcCtD
Niacin—Headache—Epirubicin—pancreatic cancer	9.89e-05	0.000279	CcSEcCtD
Niacin—HCAR3—Signaling Pathways—PIK3CG—pancreatic cancer	9.8e-05	0.000392	CbGpPWpGaD
Niacin—HCAR3—Signaling by GPCR—NRAS—pancreatic cancer	9.8e-05	0.000392	CbGpPWpGaD
Niacin—SLC16A3—Hemostasis—SRC—pancreatic cancer	9.73e-05	0.000389	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—EGF—pancreatic cancer	9.69e-05	0.000388	CbGpPWpGaD
Niacin—Dizziness—Doxorubicin—pancreatic cancer	9.66e-05	0.000273	CcSEcCtD
Niacin—SLC16A1—Hemostasis—PLAU—pancreatic cancer	9.61e-05	0.000385	CbGpPWpGaD
Niacin—SLC16A3—Hemostasis—VEGFA—pancreatic cancer	9.47e-05	0.000379	CbGpPWpGaD
Niacin—HCAR2—Signaling by GPCR—EGFR—pancreatic cancer	9.42e-05	0.000377	CbGpPWpGaD
Niacin—Nausea—Epirubicin—pancreatic cancer	9.38e-05	0.000265	CcSEcCtD
Niacin—QPRT—Metabolism—PTEN—pancreatic cancer	9.37e-05	0.000375	CbGpPWpGaD
Niacin—SLC16A3—Hemostasis—NRAS—pancreatic cancer	9.36e-05	0.000374	CbGpPWpGaD
Niacin—QPRT—Disease—MYC—pancreatic cancer	9.29e-05	0.000372	CbGpPWpGaD
Niacin—Vomiting—Doxorubicin—pancreatic cancer	9.29e-05	0.000262	CcSEcCtD
Niacin—QPRT—Disease—TGFB1—pancreatic cancer	9.27e-05	0.000371	CbGpPWpGaD
Niacin—Rash—Doxorubicin—pancreatic cancer	9.21e-05	0.00026	CcSEcCtD
Niacin—Dermatitis—Doxorubicin—pancreatic cancer	9.2e-05	0.00026	CcSEcCtD
Niacin—Headache—Doxorubicin—pancreatic cancer	9.15e-05	0.000258	CcSEcCtD
Niacin—QPRT—Disease—EGFR—pancreatic cancer	9.09e-05	0.000364	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—PIK3CD—pancreatic cancer	9.09e-05	0.000364	CbGpPWpGaD
Niacin—HCAR2—GPCR downstream signaling—PIK3CA—pancreatic cancer	9e-05	0.00036	CbGpPWpGaD
Niacin—HCAR3—Signaling by GPCR—EGFR—pancreatic cancer	8.93e-05	0.000357	CbGpPWpGaD
Niacin—HCAR2—Signaling by GPCR—KRAS—pancreatic cancer	8.9e-05	0.000356	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—TYMS—pancreatic cancer	8.75e-05	0.00035	CbGpPWpGaD
Niacin—NNMT—Metabolism—PTEN—pancreatic cancer	8.71e-05	0.000348	CbGpPWpGaD
Niacin—SLC16A3—Hemostasis—TGFB1—pancreatic cancer	8.69e-05	0.000348	CbGpPWpGaD
Niacin—Nausea—Doxorubicin—pancreatic cancer	8.68e-05	0.000245	CcSEcCtD
Niacin—HCAR3—Signaling Pathways—PIK3CD—pancreatic cancer	8.62e-05	0.000345	CbGpPWpGaD
Niacin—QPRT—Disease—KRAS—pancreatic cancer	8.59e-05	0.000344	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—PIK3CG—pancreatic cancer	8.55e-05	0.000342	CbGpPWpGaD
Niacin—HCAR3—GPCR downstream signaling—PIK3CA—pancreatic cancer	8.53e-05	0.000342	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—EGF—pancreatic cancer	8.45e-05	0.000338	CbGpPWpGaD
Niacin—HCAR3—Signaling by GPCR—KRAS—pancreatic cancer	8.43e-05	0.000338	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—GLP1R—pancreatic cancer	8.43e-05	0.000337	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—DPYD—pancreatic cancer	8.29e-05	0.000332	CbGpPWpGaD
Niacin—HCAR2—Signaling by GPCR—PIK3CA—pancreatic cancer	8.17e-05	0.000327	CbGpPWpGaD
Niacin—SLC16A3—Hemostasis—KRAS—pancreatic cancer	8.05e-05	0.000322	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—PIK3CB—pancreatic cancer	7.92e-05	0.000317	CbGpPWpGaD
Niacin—QPRT—Disease—PIK3CA—pancreatic cancer	7.89e-05	0.000316	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—SLC2A2—pancreatic cancer	7.87e-05	0.000315	CbGpPWpGaD
Niacin—HCAR3—Signaling by GPCR—PIK3CA—pancreatic cancer	7.75e-05	0.00031	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—CXCL8—pancreatic cancer	7.61e-05	0.000305	CbGpPWpGaD
Niacin—HCAR2—Signaling by GPCR—HRAS—pancreatic cancer	7.56e-05	0.000303	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—PIK3CD—pancreatic cancer	7.52e-05	0.000301	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—PIK3CB—pancreatic cancer	7.51e-05	0.000301	CbGpPWpGaD
Niacin—SLC16A3—Hemostasis—PIK3CA—pancreatic cancer	7.4e-05	0.000296	CbGpPWpGaD
Niacin—HCAR2—GPCR downstream signaling—AKT1—pancreatic cancer	7.35e-05	0.000294	CbGpPWpGaD
Niacin—QPRT—Disease—HRAS—pancreatic cancer	7.3e-05	0.000292	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—CASP3—pancreatic cancer	7.29e-05	0.000292	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—CXCL8—pancreatic cancer	7.22e-05	0.000289	CbGpPWpGaD
Niacin—HCAR3—Signaling by GPCR—HRAS—pancreatic cancer	7.17e-05	0.000287	CbGpPWpGaD
Niacin—SLC16A3—Hemostasis—TP53—pancreatic cancer	7.16e-05	0.000286	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—APOE—pancreatic cancer	7.12e-05	0.000285	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—CCND1—pancreatic cancer	7.09e-05	0.000284	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—CTNNB1—pancreatic cancer	7.02e-05	0.000281	CbGpPWpGaD
Niacin—HCAR3—GPCR downstream signaling—AKT1—pancreatic cancer	6.97e-05	0.000279	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—CASP3—pancreatic cancer	6.91e-05	0.000276	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—MMP9—pancreatic cancer	6.89e-05	0.000276	CbGpPWpGaD
Niacin—SLC16A3—Hemostasis—HRAS—pancreatic cancer	6.85e-05	0.000274	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—PTEN—pancreatic cancer	6.85e-05	0.000274	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—CCND1—pancreatic cancer	6.72e-05	0.000269	CbGpPWpGaD
Niacin—HCAR2—Signaling by GPCR—AKT1—pancreatic cancer	6.68e-05	0.000267	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—CTNNB1—pancreatic cancer	6.66e-05	0.000266	CbGpPWpGaD
Niacin—QPRT—Metabolism—PIK3CA—pancreatic cancer	6.61e-05	0.000264	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—PIK3CB—pancreatic cancer	6.55e-05	0.000262	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—MMP9—pancreatic cancer	6.53e-05	0.000261	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—PTEN—pancreatic cancer	6.49e-05	0.00026	CbGpPWpGaD
Niacin—QPRT—Disease—AKT1—pancreatic cancer	6.44e-05	0.000258	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—PIK3CG—pancreatic cancer	6.42e-05	0.000257	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—SRC—pancreatic cancer	6.35e-05	0.000254	CbGpPWpGaD
Niacin—HCAR3—Signaling by GPCR—AKT1—pancreatic cancer	6.33e-05	0.000253	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—PPARG—pancreatic cancer	6.2e-05	0.000248	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—VEGFA—pancreatic cancer	6.18e-05	0.000247	CbGpPWpGaD
Niacin—NNMT—Metabolism—PIK3CA—pancreatic cancer	6.14e-05	0.000246	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—STAT3—pancreatic cancer	6.12e-05	0.000245	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—NRAS—pancreatic cancer	6.11e-05	0.000244	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—CD44—pancreatic cancer	6.09e-05	0.000244	CbGpPWpGaD
Niacin—SLC16A3—Hemostasis—AKT1—pancreatic cancer	6.04e-05	0.000242	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—SRC—pancreatic cancer	6.02e-05	0.000241	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—VEGFA—pancreatic cancer	5.86e-05	0.000235	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—GCG—pancreatic cancer	5.84e-05	0.000234	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—STAT3—pancreatic cancer	5.8e-05	0.000232	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—NRAS—pancreatic cancer	5.79e-05	0.000232	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—MYC—pancreatic cancer	5.69e-05	0.000228	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—TGFB1—pancreatic cancer	5.67e-05	0.000227	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—PIK3CD—pancreatic cancer	5.65e-05	0.000226	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—EGFR—pancreatic cancer	5.56e-05	0.000223	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—STK11—pancreatic cancer	5.49e-05	0.00022	CbGpPWpGaD
Niacin—QPRT—Metabolism—AKT1—pancreatic cancer	5.4e-05	0.000216	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—MYC—pancreatic cancer	5.39e-05	0.000216	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—TGFB1—pancreatic cancer	5.38e-05	0.000215	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—EGFR—pancreatic cancer	5.27e-05	0.000211	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—KRAS—pancreatic cancer	5.26e-05	0.00021	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—SRC—pancreatic cancer	5.25e-05	0.00021	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—VEGFA—pancreatic cancer	5.12e-05	0.000205	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—NRAS—pancreatic cancer	5.05e-05	0.000202	CbGpPWpGaD
Niacin—NNMT—Metabolism—AKT1—pancreatic cancer	5.02e-05	0.000201	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—KRAS—pancreatic cancer	4.98e-05	0.000199	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—PIK3CB—pancreatic cancer	4.92e-05	0.000197	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—PTGS2—pancreatic cancer	4.88e-05	0.000195	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—PIK3CA—pancreatic cancer	4.83e-05	0.000193	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—TYMS—pancreatic cancer	4.72e-05	0.000189	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—TGFB1—pancreatic cancer	4.69e-05	0.000188	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—TP53—pancreatic cancer	4.67e-05	0.000187	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—PIK3CA—pancreatic cancer	4.58e-05	0.000183	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—HRAS—pancreatic cancer	4.47e-05	0.000179	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—TP53—pancreatic cancer	4.43e-05	0.000177	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—KRAS—pancreatic cancer	4.35e-05	0.000174	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—PTEN—pancreatic cancer	4.25e-05	0.00017	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—HRAS—pancreatic cancer	4.24e-05	0.000169	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—PIK3CA—pancreatic cancer	4e-05	0.00016	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—AKT1—pancreatic cancer	3.94e-05	0.000158	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—TP53—pancreatic cancer	3.87e-05	0.000155	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—PRSS1—pancreatic cancer	3.84e-05	0.000154	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—APOE—pancreatic cancer	3.84e-05	0.000154	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—AKT1—pancreatic cancer	3.74e-05	0.00015	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—HRAS—pancreatic cancer	3.7e-05	0.000148	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—PIK3CG—pancreatic cancer	3.47e-05	0.000139	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—PPARG—pancreatic cancer	3.35e-05	0.000134	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—ARG2—pancreatic cancer	3.33e-05	0.000133	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—AKT1—pancreatic cancer	3.26e-05	0.000131	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—PIK3CD—pancreatic cancer	3.05e-05	0.000122	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—PIK3CA—pancreatic cancer	3e-05	0.00012	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—TYMP—pancreatic cancer	2.91e-05	0.000117	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—PIK3CB—pancreatic cancer	2.66e-05	0.000106	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—PTGS2—pancreatic cancer	2.63e-05	0.000105	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—AKT1—pancreatic cancer	2.45e-05	9.81e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—GLP1R—pancreatic cancer	2.35e-05	9.4e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—DPYD—pancreatic cancer	2.31e-05	9.24e-05	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—PTEN—pancreatic cancer	2.3e-05	9.19e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—SLC2A2—pancreatic cancer	2.19e-05	8.77e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—CD44—pancreatic cancer	1.7e-05	6.79e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—GCG—pancreatic cancer	1.63e-05	6.51e-05	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—PIK3CA—pancreatic cancer	1.62e-05	6.48e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—STK11—pancreatic cancer	1.53e-05	6.12e-05	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—AKT1—pancreatic cancer	1.32e-05	5.3e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—TYMS—pancreatic cancer	1.32e-05	5.27e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—APOE—pancreatic cancer	1.07e-05	4.28e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—PIK3CG—pancreatic cancer	9.66e-06	3.87e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—PPARG—pancreatic cancer	9.32e-06	3.73e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—PIK3CD—pancreatic cancer	8.49e-06	3.4e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—PIK3CB—pancreatic cancer	7.4e-06	2.96e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—PTGS2—pancreatic cancer	7.33e-06	2.94e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—PTEN—pancreatic cancer	6.4e-06	2.56e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—PIK3CA—pancreatic cancer	4.51e-06	1.81e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—AKT1—pancreatic cancer	3.69e-06	1.48e-05	CbGpPWpGaD
